Activation of factor IX zymogen results in exposure of a binding site for low-density lipoprotein receptor-related protein.
暂无分享,去创建一个
P. Lenting | A. V. van Zonneveld | H. Pannekoek | K. Mertens | J. Neels | A. J. Zonneveld | B. M. V. D. Berg | B. V. D. van den Berg | H. ter Maat | Hans ter Maat
[1] I. Mikhailenko,et al. Role of the Low Density Lipoprotein-related Protein Receptor in Mediation of Factor VIII Catabolism* , 1999, The Journal of Biological Chemistry.
[2] A. V. van Zonneveld,et al. The Second and Fourth Cluster of Class A Cysteine-rich Repeats of the Low Density Lipoprotein Receptor-related Protein Share Ligand-binding Properties* , 1999, The Journal of Biological Chemistry.
[3] J. V. van Mourik,et al. The Light Chain of Factor VIII Comprises a Binding Site for Low Density Lipoprotein Receptor-related Protein* , 1999, The Journal of Biological Chemistry.
[4] A. V. van Zonneveld,et al. The second and fourth cluster of class a cysteinerich repeats of the low density lipoprotein receptor-related protein (LRP) share ligandbinding properties* , 1999 .
[5] J. Gliemann,et al. Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. , 1998, Biological chemistry.
[6] H. Pannekoek,et al. Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor , 1998 .
[7] J. Miletich,et al. The low-density lipoprotein receptor-related protein (LRP) mediates clearance of coagulation factor Xa in vivo. , 1998, Blood.
[8] R. Iozzo,et al. The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. , 1997, The Journal of clinical investigation.
[9] A. V. van Zonneveld,et al. Molecular Analysis of Ligand Binding to the Second Cluster of Complement-type Repeats of the Low Density Lipoprotein Receptor-related Protein , 1997, The Journal of Biological Chemistry.
[10] M. Ishihara. Animal Cell Mutants Defective in Glycosaminoglycan Biosynthesis , 1997 .
[11] A. Minton,et al. Kinetic analysis of biosensor data: elementary tests for self-consistency. , 1996, Trends in biochemical sciences.
[12] M. Shakibaei,et al. Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans , 1996, The Journal of experimental medicine.
[13] J. van den Born,et al. Identification of the endothelial cell binding site for factor IX. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Strickland,et al. Cellular Internalization and Degradation of Antithrombin III-Thrombin, Heparin Cofactor II-Thrombin, and -Antitrypsin-Trypsin Complexes Is Mediated by the Low Density Lipoprotein Receptor-related Protein (*) , 1996, The Journal of Biological Chemistry.
[15] P. Lenting,et al. The Sequence GluLys of Human Blood Coagulation Factor VIII Comprises a Binding Site for Activated Factor IX (*) , 1996, The Journal of Biological Chemistry.
[16] B. Hyman,et al. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation , 1995, Cell.
[17] J. V. van Mourik,et al. Cleavage at Arginine 145 in Human Blood Coagulation Factor IX Converts the Zymogen into a Factor VIII Binding Enzyme (*) , 1995, The Journal of Biological Chemistry.
[18] S. Leppla,et al. Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein [published erratum appears in J Cell Biol 1995 Aug;130(4):1015] , 1995, The Journal of cell biology.
[19] I. Mikhailenko,et al. Low Density Lipoprotein Receptor-related Protein/-Macroglobulin Receptor Mediates the Cellular Internalization and Degradation of Thrombospondin , 1995, The Journal of Biological Chemistry.
[20] D. Strickland,et al. The Cellular Internalization and Degradation of Hepatic Lipase Is Mediated by Low Density Lipoprotein Receptor-related Protein and Requires Cell Surface Proteoglycans (*) , 1995, The Journal of Biological Chemistry.
[21] J. Baron,et al. The Molecular Basis of Blood Diseases , 1994 .
[22] D. Lawrence,et al. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. , 1994, The Journal of biological chemistry.
[23] A. Schwartz,et al. The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] K. Mertens,et al. The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes , 1994, British journal of haematology.
[25] Raymond,et al. Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. , 1993, The Journal of clinical investigation.
[26] J. Henkin,et al. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates cellular uptake of pro-urokinase. , 1993, The Journal of biological chemistry.
[27] M. Waknitz,et al. Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans. , 1993, The Journal of biological chemistry.
[28] D. Cines,et al. Determinants of binding and internalization of tissue-type plasminogen activator by human vascular smooth muscle and endothelial cells. , 1993, The Journal of biological chemistry.
[29] D. Bilheimer,et al. Insulin stimulates receptor-mediated uptake of apoE-enriched lipoproteins and activated alpha 2-macroglobulin in adipocytes. , 1993, The Journal of biological chemistry.
[30] A. Schwartz,et al. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Sambrook,et al. Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[32] S. Moestrup,et al. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. , 1992, The Journal of biological chemistry.
[33] K Fujikawa,et al. The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.
[34] S. Moestrup,et al. Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors. , 1991, The Journal of biological chemistry.
[35] D. Strickland,et al. The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin , 1990, The Journal of cell biology.
[36] S. K. Moestrup,et al. Purification of the human placental α2‐macroglobulin receptor , 1989 .
[37] M. Griffith,et al. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors. , 1983, The Journal of clinical investigation.
[38] M. Drillings,et al. Binding of factors IX and IXa to cultured vascular endothelial cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[39] S. Schwartz,et al. Binding of coagulation factors IX and X to the endothelial cell surface. , 1983, Biochemical and biophysical research communications.
[40] H. Jörnvall,et al. The Active Site Of Antithrombin. Release Of The Same Proteolytically Cleaved Form Of The Inhibitor From Complexes With Factor IXa, Factor Xa And Thrombin , 1982, Thrombosis and Haemostasis.
[41] K. Fujikawa,et al. Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom. , 1978, The Journal of biological chemistry.
[42] E. Davie,et al. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. , 1977, Biochemistry.
[43] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[44] K. Fujikawa,et al. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent). , 1974, Biochemistry.
[45] R. Mahley,et al. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. , 1999, Journal of lipid research.
[46] K. Mann,et al. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. , 1990, Blood.
[47] S. Moestrup,et al. Purification of the human placental alpha 2-macroglobulin receptor. , 1989, FEBS letters.
[48] G. Stamatoyannopoulos,et al. The molecular basis of blood diseases , 1987 .